-

HCA Healthcare Appoints John W. Chidsey, III as New Independent Director

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced that its board of directors has appointed John W. Chidsey, III as an independent director, effective July 15, 2025. With his addition, HCA Healthcare’s board of directors increases from nine to ten members.

Mr. Chidsey will serve as a member of HCA Healthcare’s audit and compliance committee, compensation committee and patient safety and quality of care committee.

Mr. Chidsey most recently served as the global chief executive officer of Subway. He previously served as chief executive officer of Burger King Holdings, Inc. and held significant leadership roles at Cendant Corporation. Earlier in his career, he also held various senior financial leadership roles at PepsiCo.

Mr. Chidsey also currently serves on the board of Norwegian Cruise Line Holdings Ltd. and previously served on the boards of Encompass Health Corporation, Burger King Holdings, Inc. (as chairman) and Brinker International, Inc.

“John Chidsey’s distinguished career demonstrates his extensive experience in leading corporate strategy at large, complex public and private companies, and we are confident he will provide invaluable insight as a board member,” said Thomas F. Frist III, chairman of the board of HCA Healthcare. “John’s financial, operational and executive leadership experience and expertise will complement HCA Healthcare’s commitment to the care and improvement of human life. We are pleased to announce his addition to our board.”

Mr. Chidsey holds a B.A. degree from Davidson College, as well as MBA and J.D. degrees from Emory University.

About HCA Healthcare

Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 192 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 44 million annual patient encounters to advance science, improve patient care and save lives.

All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc., and its affiliates.

Contacts

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

HCA Healthcare

NYSE:HCA

Release Versions

Contacts

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

More News From HCA Healthcare

More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that 102 of its hospitals have been recognized by Healthgrades for excellence in specialty care, more than any other health system in the country. The 2027 recognitions reflect clinical outcomes in important areas of patient care, including surgical care, emergency medicine and orthopedic surgery. For patients and families making healthcare decisions, these recog...

HCA Healthcare Reports Third Quarter 2026 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026. Key third quarter metrics (all percentage changes compare 3Q 2026 to 3Q 2025 unless otherwise noted): Revenues increased 3.6 percent to $19.849 billion Net income attributable to HCA Healthcare, Inc. declined 3.9 percent to $1.579 billion Diluted earnings per share increased 4.5 percent to $7.27 per diluted share, and diluted earning...

HCA Healthcare to Host Eighth Annual “Crush the Crisis” National Prescription Drug Take Back Day

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced it will host its eighth annual “Crush the Crisis” national prescription drug take back day. On Saturday, Oct. 24, 2026, HCA Healthcare facilities from across the country will partner with local law enforcement to help patients, families and communities safely and anonymously dispose of unused or expired medications at more than 130 collection sites, helping keep...
Back to Newsroom